Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T_helper cell response

References

• Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood. 2004;103:2003–8.
   PubMed Web of Science ®Google Scholar
• Ljungman P, Brand R, Einsele H, . Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood. 2003;102:4255–60.
   PubMed Web of Science ®Google Scholar
• Boeckh M, Nichols WG, Papanicolaou G, . Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9:543–58.
   PubMed Web of Science ®Google Scholar
• Ljungman P, Reusser P, de la Camara R, . Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant. 2004;33:1075–81.
   PubMedGoogle Scholar
• Peggs KS, Verfuerth S, Pizzey A, . Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet. 2003;362:1375–7.
   PubMed Web of Science ®Google Scholar
• Einsele H, Roosnek E, Rufer N, . Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002;99:3916–3922.
   PubMed Web of Science ®Google Scholar
• Bunde T, Kirchner A, Hoffmeister B, . Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med. 2005; 201:1031–6.
   PubMed Web of Science ®Google Scholar
• Cobbold M, Khan N, Pourgheysari B, . Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med. 2005;202:379–86.
   PubMed Web of Science ®Google Scholar
• Schottker B, Feuchtinger T, Schumm M, . Five donors–one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors. Nat Clin Pract Oncol. 2008;5:291–5.
   PubMedGoogle Scholar
• Brossart P, Wirths S, Stuhler G, . Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood. 2000;96:3102–8.
   PubMed Web of Science ®Google Scholar
• Grigoleit GU, Kapp M, Hebart H, . Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor. J Infect Dis. 2007; 196: 699–704.
   PubMed Web of Science ®Google Scholar
• Riddell SR, Walter BA, Gilbert MJ, Greenberg PD. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones. Bone Marrow Transplant. 1994;14(Suppl 4):S78–84.
   Google Scholar
• Walter EA, Greenberg PD, Gilbert MJ, . Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333:1038–44.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109–18.
   PubMed Web of Science ®Google Scholar
• Feuchtinger T, Matthes-Martin S, Richard C, . Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2006;134: 64–76.
   PubMed Web of Science ®Google Scholar
• Schumm M, Feuchtinger T, Pfeiffer M, . Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation. Bone Marrow Transplant. 2007;39:767–73.
   PubMed Web of Science ®Google Scholar
• Gohring K, Feuchtinger T, Mikeler E, . Dynamics of the emergence of a human cytomegalovirus UL97 mutant strain conferring ganciclovir resistance in a pediatric stem-cell transplant recipient. J Mol Diagn. 2009;11:364–8.
   PubMedGoogle Scholar
• Eckle T, Prix L, Jahn G, . Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood. 2000;96:3286–9.
   PubMed Web of Science ®Google Scholar
• Serangeli C, Bicanic O, Scheible MH, . Ex vivo detection of adenovirus specific CD4(+) T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(helper) cells following stem cell transplantation. Virology. 2010;397(2):277–84. Epub 2009 Dec 3.
   PubMedGoogle Scholar
• Sun JC, Williams MA, Bevan MJ. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol. 2004;5:927–33.
   PubMed Web of Science ®Google Scholar